Qkine and Enantis sign a licensing deal to bring hyperstable FGF2-STAB® to the global stem cell community
Previous
Previous
Privitar Expands Executive Leadership Team with Appointments of Victoria Normark as Chief Technology Officer, Pat Walsh as Chief Marketing Officer, and Bill Ziske as SVP of Sales North America
Next
Next